Clinical trial
Feasibility of Lecanemab Registry and Clinical Outcome Measures
NCT06285448 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility of Lecanemab Registry and Clinical Outcome Measures
- Lead sponsor
- HealthPartners Institute
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- January 2, 2024
- Completion date
- June 30, 2028
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.